Over-the-counter drug · UNAPPROVED HOMEOPATHIC
Lyme and Co-Infection Nosode NDC 58048-0005
Angelica archangelica root 2 [hp_X]/mL + 19 more ingredients · Liquid · Oral · Bhp Holdings, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 58048-0005-1 | 5804800050158048000501 | 60 mL in 1 BOTTLE, DROPPER (58048-0005-1)Marketed from Mar 17, 2020 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Lyme and Co-Infection Nosode
- Generic name (nonproprietary)
- angelica archangelica, kali muriaticum, yucca filamentosa, cartilago suis, phytolacca decandra, hydrastis canadensis, rhus tox, causticum, magnesia phosphorica, manganum metallicum, oxalicum acidum, arnica montana, babesia microti, borrelia burgdorferi nosode, latrodectus mactans, citricum acidum, cytomegalovirus nosode, rickettsia nosode (rickettsia prowazekii), chlamydia trachomatis, ledum palustre
- Active ingredients
- Angelica archangelica root — 2 [hp_X]/mLPotassium chloride — 3 [hp_X]/mLYucca filamentosa — 3 [hp_X]/mLSus scrofa cartilage — 4 [hp_X]/mLPhytolacca americana root — 4 [hp_X]/mLGoldenseal — 5 [hp_X]/mLToxicodendron pubescens leaf — 6 [hp_X]/mLCausticum — 6 [hp_X]/mLMagnesium phosphate, Dibasic trihydrate — 8 [hp_X]/mLManganese — 8 [hp_X]/mLOxalic acid — 8 [hp_X]/mLArnica montana — 8 [hp_X]/mLBabesia microti — 12 [hp_X]/mLBorrelia burgdorferi — 12 [hp_X]/mLLatrodectus mactans — 12 [hp_X]/mLAnhydrous citric acid — 6 [hp_C]/mLHuman herpesvirus 5 — 6 [hp_C]/mLRickettsia prowazekii — 8 [hp_C]/mLChlamydia trachomatis — 12 [hp_C]/mLLedum palustre twig — 30 [hp_C]/mL
- Dosage form
- Liquid
- Route
- Oral
- Labeler
- Bhp Holdings, Inc.NDC labeler code 58048
- Product type
- Over-the-counter drug
- Marketing category
- Unapproved homeopathic
- Marketing start
- Marketing end
- Other FDA classes
- Acidifying Activity (Mechanism)Calcium Chelating Activity (Mechanism)Decreased Coagulation Factor Activity (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Small Intestine Fluid/Electrolyte Absorption (Physiologic effect)Magnesium Ion Exchange Activity (Mechanism)Osmotic Activity (Mechanism)Osmotic Activity (Mechanism)Potassium Compounds (Chemical structure)Stimulation Large Intestine Fluid/Electrolyte Secretion (Physiologic effect)
- Identifiers
- Product ID 58048-0005_88e0c163-99e8-45bb-8911-8d29370dd909SPL ID 88e0c163-99e8-45bb-8911-8d29370dd909SPL set ID f6186157-256f-4454-b122-f7665e3286f4UNII DTN01M69SN, 660YQ98I10, T6VR38UJ9I, 73ECW5WG2F, 11E6VI8VEG, ZW3Z11D0JV, 6IO182RP7A, DD5FO1WKFU, HF539G9L3Q, 42Z2K6ZL8P, 9E7R5L6H31, O80TY208ZW, 1948X6KEG3, 0J8NV9V5Q8, XJJ7QA858R, XF417D3PSL, 7COI029E6K, TVS414L9M5, T6NI39QU44, 877L01IZ0P
- Pharmacologic class
- Anti-coagulant; Calculi Dissolution Agent; Osmotic Laxative; Potassium Salt
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N458048000501followed by a unit qualifier and the quantityPackage 58048-0005-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Label details couldn’t be retrieved right now. Open the label on DailyMed.
About NDC 58048-0005
- What is NDC 58048-0005?
- 58048-0005 is the product NDC for Lyme and Co-Infection Nosode, Angelica archangelica root 2 [hp_X]/mL + 19 more ingredients liquid, listed with the FDA by Bhp Holdings, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Lyme and Co-Infection Nosode (Angelica Archangelica, Kali Muriaticum, Yucca Filamentosa, Cartilago Suis, Phytolacca Decandra, Hydrastis Canadensis, Rhus Tox, Causticum, Magnesia Phosphorica, Manganum Metallicum, Oxalicum Acidum, Arnica Montana, Babesia Microti, Borrelia Burgdorferi Nosode, Latrodectus Mactans, Citricum Acidum, Cytomegalovirus Nosode, Rickettsia Nosode (rickettsia prowazekii), Chlamydia Trachomatis, Ledum Palustre).
- What is the active ingredient?
- Angelica archangelica root, Potassium chloride, Yucca filamentosa, Sus scrofa cartilage, Phytolacca americana root, Goldenseal, Toxicodendron pubescens leaf, Causticum, Magnesium phosphate, Dibasic trihydrate, Manganese, Oxalic acid, Arnica montana, Babesia microti, Borrelia burgdorferi, Latrodectus mactans, Anhydrous citric acid, Human herpesvirus 5, Rickettsia prowazekii, Chlamydia trachomatis, Ledum palustre twig.
- Who is the labeler?
- Bhp Holdings, Inc., NDC labeler code 58048. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Lyme and Co-Infection Nosode?
- None: this is the only finished product listed under this name.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.